Revascularization in left ventricular dysfunction: an update
Bobby Yanagawa1, Jessica Lee1, John D Puskas2
1Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Insights
Surgical revascularization improves long-term survival for patients with coronary artery disease and left ventricular dysfunction. Coronary artery bypass grafting offers better outcomes than percutaneous coronary revascularization in this high-risk group.
Area of Science:
- Cardiology
- Cardiac Surgery
Background:
- Patients with coronary artery disease (CAD) and left ventricular dysfunction (LVD) represent a high-risk population.
- The Surgical Treatment for Ischemic Heart Failure (STICH) Trial is a key study in this area.
Purpose of the Study:
- To review revascularization strategies for patients with CAD and LVD.
- To evaluate the comparative effectiveness of surgical versus percutaneous revascularization.
Main Methods:
- Review of major prospective trials, including the STICH Trial.
- Analysis of observational studies comparing coronary artery bypass grafting (CABG) and percutaneous coronary revascularization (PCI).
Main Results:
- The STICH Trial showed lower all-cause mortality with surgical revascularization compared to medical therapy at 10 years.
- Observational data indicate CABG superiority over PCI for long-term survival and reduced need for repeat procedures in LVD patients.
- Surgical revascularization has short-term risks but offers improved long-term outcomes for LVD patients.
Conclusions:
- Surgical revascularization provides a long-term survival benefit for patients with significant CAD and LVD.
- Consideration for multiarterial grafting and off-pump procedures may benefit selected LVD patients undergoing CABG.
- Further research is needed to identify optimal candidates for surgical versus percutaneous revascularization.
Purpose Of Review:
The purpose of this article is to provide an overview of revascularization in patients with coronary artery disease (CAD) and left ventricular dysfunction (LVD).
Recent Findings:
Patients with significant CAD and LVD are a high-risk patient population. They make up a minority of the cases from the largest, prospective coronary revascularization trials. The Surgical Treatment for Ischemic Heart Failure (STICH) Trial and its substudies are the most important and well cited in this field. The 10-year data from STICH showed that surgical revascularization was associated with lower all-cause mortality compared with medical therapy. Several smaller studies have confirmed that surgical revascularization carries a significant risk of short-term mortality but overall improved long-term outcomes in patients with LVD. Data from multiple observational studies further confirm that coronary artery bypass graft (CABG) is superior to percutaneous coronary revascularization for long-term survival and freedom from repeat revascularization in patients with LVD. We suggest that patients with LVD undergoing CABG should be considered for multiarterial grafting and that some patients may benefit from an off-pump procedure.
Summary:
Surgical revascularization confers a long-term survival benefit in patients with significant CAD and LVD. Further studies will be needed to precisely determine the ideal candidate for surgical versus percutaneous revascularization.
Related Concept Videos
Cardiac Catheterization III: Left Heart Catheterization
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Anatomy of the Heart
Schemas
Fixing Double-strand Breaks
Reaction Quotient


